Targeting CD40L: a promising therapeutic approach
Clin Diagn Lab Immunol
.
2004 Jul;11(4):635-41.
doi: 10.1128/CDLI.11.4.635-641.2004.
Authors
Dimitris Daoussis
1
,
Andrew P Andonopoulos
,
Stamatis-Nick C Liossis
Affiliation
1
Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Patras, Greece.
PMID:
15242934
PMCID:
PMC440614
DOI:
10.1128/CDLI.11.4.635-641.2004
No abstract available
Publication types
Review
MeSH terms
Animals
Antigen-Presenting Cells / immunology*
CD40 Ligand / immunology*
Humans
Lymphocyte Activation / immunology*
T-Lymphocytes / immunology*
Substances
CD40 Ligand